The inhibition of ABCB1/MDR1 or ABCG2/BCRP enables doxorubicin to eliminate liver cancer stem cells.
| Autor: | Yin, Wang1, Xiang, Dongxi2,3,4, Wang, Tao5,6, Zhang, Yumei1, Pham, Cuong V.1, Zhou, Shufeng7, Jiang, Guoqin8, Hou, Yingchun9, Zhu, Yimin10, Han, Yinglu11, Qiao, Liang12, Tran, Phuong H.-L.1 phuong.tran1@deakin.edu.au, Duan, Wei1 wei.duan@deakin.edu.au |
|---|---|
| Zdroj: | Scientific Reports. 5/24/2021, Vol. 11 Issue 1, p1-13. 13p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|